Table 3 |
Salmeterol |
α‑hydroxysalmeterol |
Urine limit of quantification |
0.12 ngmL-1 |
0.14 ngmL-1 |
Urine intermediate precision (level 1) |
10 % (0.20 ngmL-1) |
12 % (0.50 ngmL-1) |
Urine intermediate precision (level 2) |
11 % (1 ngmL-1) |
10 % (5 ngmL-1) |
Recovery (Level 1) |
88 % (0.2 ngmL-1) |
62 % (0.5 ngmL-1) |
Recovery (Level 2) |
73 % (1 ngmL-1) |
73 % (5 ngmL-1) |
Serum limit of quantification |
0.04 ngmL-1 |
0.05 ngmL-1 |
Serum intermediate precision (0.025 ngmL-1) |
13 % |
18 % |
Serum intermediate precision (0.20 ngmL-1) |
5 % |
22 % |
Serum intermediate precision (1 ngmL-1) |
4 % |
16 % |
Recovery (0.025 ngmL-1) |
97 % |
87 % |
Recovery (0.2 ngmL-1) |
78 % |
98 % |
Recovery (1 ngmL-1) |
56 % |
83 % |